Supriya Lifescience Ltd. Investor Presentation

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation.

pdf

Supriya Lifescience Ltd.

14 Feb 2023

802.65

1.94%

Investor Presentation

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation.

pdf

Supriya Lifescience Ltd.

11 Nov 2022

802.65

1.94%

Investor Presentation

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation. You are requested to kindly take the same on record.

pdf

Supriya Lifescience Ltd.

13 Aug 2022

802.65

1.94%

Investor Presentation

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

pdf

Supriya Lifescience Ltd.

21 May 2022

802.65

1.94%

Investor Presentation

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

This has a reference to our intimation letter dated May 21, 2022, wherein the Company has submitted Investor Presentation, inter-alia, to the Stock Exchanges. In connection herewith, please find enclosed herewith revised Investor presentation. You are requested to kindly take the same on record.

pdf

Supriya Lifescience Ltd.

21 May 2022

802.65

1.94%

Investor Presentation

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

pdf

Supriya Lifescience Ltd.

21 Jan 2022

802.65

1.94%

Investor Presentation

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation. You are requested to kindly take the same on record.

pdf